Filing Flows › Comparisons › STLN vs LFMD
Starling Oncology vs LifeMD: STLN and LFMD compared
Starling Oncology is the larger company: $170M of revenue in its latest quarter (Q3 2026) against $47.3M for LifeMD (Q2 2026). Starling Oncology is growing faster (+24% against -4% a year earlier). Starling Oncology is more profitable, with an operating margin of -1.8% against -15.1%.
Where the money goes: STLN and LFMD
Starling Oncology (STLN) · Q3 2026
Starling Oncology, Q3 2026: revenue $170M (+24% year over year), operating margin -1.8%, net loss $15.7M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
LifeMD (LFMD) · Q2 2026
LifeMD, Q2 2026: revenue $47.3M (-4% year over year), operating margin -15.1%, net loss $7.1M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
| Starling Oncology (STLN) | LifeMD (LFMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $170M | $47.3M |
| Revenue growth, Y/Y | +24% | -4% |
| Operating margin | -1.8% | -15.1% |
| Net earnings | −$15.7M | −$7.1M |
| Net margin | -9.3% | -15.0% |
| Operating cash flow | $10.1M | −$6.9M |
| Free cash flow | $8.9M | — |
Where the revenue comes from
Starling Oncology
- Specialty Pharmacy: $109M (64%)
- Patient services: $60.0M (35%)
LifeMD
- Telehealth Subscription Revenue: $29.3M (62%)
- Telehealth: $18.0M (38%)
Questions
Which is bigger, Starling Oncology or LifeMD?
Starling Oncology is the larger company: $170M of revenue in its latest quarter (Q3 2026) against $47.3M for LifeMD (Q2 2026).
Is Starling Oncology or LifeMD growing faster?
Starling Oncology is growing faster (+24% against -4% a year earlier).
Which is more profitable, Starling Oncology or LifeMD?
Starling Oncology is more profitable, with an operating margin of -1.8% against -15.1%.
More: Starling Oncology earnings · how Starling Oncology makes money · LifeMD earnings · how LifeMD makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Aug 5, 2026). Fiscal quarters can end on different dates. Not investment advice.